Cogent Biosciences Files 8-K: Other Events Reported

Ticker: COGT · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1622229

Cogent Biosciences, INC. 8-K Filing Summary
FieldDetail
CompanyCogent Biosciences, INC. (COGT)
Form Type8-K
Filed DateJul 7, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-k, other-events

TL;DR

Cogent Biosciences dropped an 8-K on 7/7/25 for 'Other Events' - need to check the details.

AI Summary

On July 7, 2025, Cogent Biosciences, Inc. filed an 8-K report. The filing indicates an 'Other Events' item, suggesting a significant, non-routine event has occurred. Further details within the filing would be needed to ascertain the specific nature and financial implications of this event.

Why It Matters

This filing signals a material event for Cogent Biosciences that could impact its operations, financial standing, or stock price. Investors should review the full filing for details.

Risk Assessment

Risk Level: medium — An 8-K filing for 'Other Events' indicates a significant, potentially material event that requires disclosure, but the lack of specific detail in the provided text necessitates caution.

Key Players & Entities

FAQ

What specific 'Other Event' is Cogent Biosciences reporting on July 7, 2025?

The provided text states the filing is for 'Other Events' but does not specify the nature of the event.

What is the Commission File Number for Cogent Biosciences?

The Commission File Number for Cogent Biosciences is 001-38443.

Where are Cogent Biosciences' principal executive offices located?

Cogent Biosciences' principal executive offices are located at 275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451.

When was Cogent Biosciences incorporated?

Cogent Biosciences is incorporated in Delaware.

What is the I.R.S. Employer Identification Number for Cogent Biosciences?

The I.R.S. Employer Identification Number for Cogent Biosciences is 46-5308248.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding Cogent Biosciences, Inc. (COGT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing